Calcium and Carmustine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium (calcium) and Carmustine (carmustine). Common drug interactions include febrile neutropenia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium and Carmustine. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,203 Calcium users. Check the latest studies of Calcium.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

24 people who take Calcium and Carmustine together, and have interactions are studied.

Calcium and Carmustine drug interactions.

What are the common drug interactions of Calcium and Carmustine, by gender? *:

female:

Febrile neutropenia (fever with reduced white blood cells)
Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)
Malignant melanoma (skin cancer rises from melancytes)
Second primary malignancy (after getting cure a cancer, a new cancer development)
Mucosal inflammation (infection of mucous membrane)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia

male:

Febrile neutropenia (fever with reduced white blood cells)
Body temperature increased
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Gamma-glutamyltransferase increased
Appendicitis (inflammation of the appendix)
Plasma cell myeloma (cancer that begins in plasma cells)
Prostate cancer
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Diarrhoea

What are the common drug interactions of Calcium and Carmustine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

n/a

40-49:

Body temperature increased
Diarrhoea
Escherichia infection (bacterial infection by escherichia coli)
Febrile neutropenia (fever with reduced white blood cells)
Frequent bowel movements
Hypotension (abnormally low blood pressure)
Leukopenia (less number of white blood cells in blood)
Pyrexia (fever)

50-59:

Pneumonia
Prostate cancer
Malignant melanoma (skin cancer rises from melancytes)
Second primary malignancy (after getting cure a cancer, a new cancer development)
Febrile neutropenia (fever with reduced white blood cells)
Mucosal inflammation (infection of mucous membrane)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)
Gamma-glutamyltransferase increased
Appendicitis (inflammation of the appendix)
Plasma cell myeloma (cancer that begins in plasma cells)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 11 people, 45.83%
Adverse Event: 5 people, 20.83%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 3 people, 12.50%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 12.50%
Oligodendroglioma (a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell): 2 people, 8.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 8.33%
Insomnia (sleeplessness): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium and Carmustine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously